SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,821 | -8.9% | 345 | -14.0% | 0.01% | -11.1% |
Q2 2023 | $45,922 | -16.9% | 401 | 0.0% | 0.01% | -18.2% |
Q1 2023 | $55,270 | +25.6% | 401 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $44,000 | +46.7% | 401 | 0.0% | 0.01% | +37.5% |
Q2 2022 | $30,000 | -11.8% | 401 | -7.6% | 0.01% | 0.0% |
Q1 2022 | $34,000 | -20.9% | 434 | -8.4% | 0.01% | -11.1% |
Q4 2021 | $43,000 | -2.3% | 474 | 0.0% | 0.01% | -18.2% |
Q3 2021 | $44,000 | +25.7% | 474 | +4.6% | 0.01% | +22.2% |
Q2 2021 | $35,000 | – | 453 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |